Dispositions - Additional Information (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Nov. 04, 2015 |
Sep. 30, 2019 |
Sep. 30, 2019 |
Dec. 31, 2018 |
|
| Asset Purchase Agreement and Ology Bioservices License Agreement [Member] | ||||
| Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items] | ||||
| Entitled to receive cash consideration | $ 4.6 | |||
| Amount received from sale of discontinued operation | $ 0.5 | $ 2.5 | ||
| Biodefense Business [Member] | ||||
| Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items] | ||||
| Royalties receivable percentage on net sales | 15.00% |
| X | ||||||||||
- Definition Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount received from sale of discontinued operation. No definition available.
|
| X | ||||||||||
- Definition Royalty receivable percentage on net sales. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|